Skip to main content

U.S. District Judge Reduces Roundup $80M Verdict To $25M

U.S. District Judge Reduces Roundup $80M Verdict To $25M

U.S. District Judge Reduces Roundup $80M Verdict To $25M

Introduction

On July 15, U.S. District Judge Vince Chhabria reduced the $80M Roundup verdict to $25 million against Bayer AG owned Monsanto after finding that punitive damages component of $75 million awarded to a plaintiff was unreasonably high.

On March 27, a federal jury awarded $5 million in compensatory and $75 million in punitive damages to the plaintiff, who was diagnosed with non-Hodgkin’s lymphoma in 2014. The judge stated that $5M as compensatory damages was sufficient as it supported the evidence presented at trial, and the $75 million as punitive damages component was constitutionally impermissible as it was 15 times the size of compensatory damages. The judge found that the punitive damages exceeded the constitutional limit and reduced the award to $20 million, with the total amounting to $25 million. Bayer still plans to appeal the verdict, and the plaintiff may appeal to Chhabria’s decision as he disagrees with any reduction in the jury verdict.

Bayer and its subsidiary, Monsanto, acquired a year ago, now face more than 15,000 Roundup lawsuits. U.S. District Judge Vince Chhabria is presiding over all the federal multidistrict litigation (MDL No. 2741; In Re: Roundup Products Liability Litigation) in the Northern District of California.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!